Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: organic cation interaction studies

References

• Angelis ID, Turco L. (2011). Caco-2 cells as a model for intestinal absorption. Curr Protoc Toxicol, 47, 20.6.1–20.6.15.
   Google Scholar
• Bosquillon C. (2010). Drug transporters in the lung–do they play a role in the biopharmaceutics of inhaled drugs? J Pharm Sci, 99, 2240–2255.
   PubMed Web of Science ®Google Scholar
• Ehrhardt C, Kneuer C, Bies C, Lehr CM, Kim KJ, Bakowsky U. (2005). Salbutamol is actively absorbed across human bronchial epithelial cell layers. Pulm Pharmacol Ther, 18, 165–170.
   PubMed Web of Science ®Google Scholar
• Fernandes CA, Vanbever R. (2009). Preclinical models for pulmonary drug delivery. Expert Opin Drug Deliv, 6, 1231–1245.
   PubMed Web of Science ®Google Scholar
• Florea BI, van der Sandt IC, Schrier SM, Kooiman K, Deryckere K, de Boer AG, Junginger HE, Borchard G. (2001). Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3). Br J Pharmacol, 134, 1555–1563.
   PubMed Web of Science ®Google Scholar
• Florea BI, Cassara ML, Junginger HE, Borchard G. (2003). Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J Control Release, 87, 131–138.
   PubMed Web of Science ®Google Scholar
• Gnadt M, Trammer B, Freiwald M, Kardziev B, Bayliss MK, Edwards CD, Schmidt M, Friedel G, Högger P. (2012). Methacholine delays pulmonary absorption of inhaled ß(2)-agonists due to competition for organic cation/carnitine transporters. Pulm Pharmacol Ther, 25, 124–134.
   PubMed Web of Science ®Google Scholar
• Grigat S, Harlfinger S, Pal S, Striebinger R, Golz S, Geerts A, Lazar A, Schömig E, Gründemann D. (2007). Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations. Biochem Pharmacol, 74, 309–316.
   PubMed Web of Science ®Google Scholar
• Grigat S, Fork C, Bach M, Golz S, Geerts A, Schömig E, Gründemann D. (2009). The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate. Drug Metab Dispos, 37, 330–337.
   PubMed Web of Science ®Google Scholar
• Hamilton KO, Backstrom G, Yazdanian MA, Audus KL. (2001). P-glycoprotein efflux pump expression and activity in Calu-3 cells. J Pharm Sci, 90, 647–658.
   PubMed Web of Science ®Google Scholar
• Haycock JW. (2011). 3D cell culture: a review of current approaches and techniques. Methods Mol Biol, 695, 1–15.
   PubMedGoogle Scholar
• Horvath G, Mendes ES, Schmid N, Schmid A, Conner GE, Salathe M, Wanner A. (2007a). The effect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells. J Allergy Clin Immunol, 120, 1103–1109.
   PubMed Web of Science ®Google Scholar
• Horvath G, Schmid N, Fragoso MA, Schmid A, Conner GE, Salathe M, Wanner A. (2007b). Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway. Am J Respir Cell Mol Biol, 36, 53–60.
   PubMed Web of Science ®Google Scholar
• Inazu M, Takeda H, Matsumiya T. (2005). Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes. J Neurochem, 94, 1427–1437.
   PubMed Web of Science ®Google Scholar
• Koepsell H, Lips K, Volk C. (2007). Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res, 24, 1227–1251.
   PubMed Web of Science ®Google Scholar
• Kummer W, Lips KS, Pfeil U. (2008). The epithelial cholinergic system of the airways. Histochem Cell Biol, 130, 219–234.
   PubMed Web of Science ®Google Scholar
• Lips KS, Volk C, Schmitt BM, Pfeil U, Arndt P, Miska D, Ermert L, Kummer W, Koepsell H. (2005). Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. Am J Respir Cell Mol Biol, 33, 79–88.
   PubMed Web of Science ®Google Scholar
• Martel F, Gründemann D, Calhau C, Schömig E. (2001). Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters. Naunyn Schmiedebergs Arch Pharmacol, 363, 40–49.
   PubMed Web of Science ®Google Scholar
• Mukherjee M, Pritchard DI, Bosquillon C. (2012). Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro. Int J Pharm, 426, 7–14.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Nakanishi T, Haruta T, Shirasaka Y, Keogh JP, Tamai I. (2010). Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption. Mol Pharm, 7, 187–195.
   PubMed Web of Science ®Google Scholar
• Ohashi R, Tamai I, Yabuuchi H, Nezu JI, Oku A, Sai Y, Shimane M, Tsuji A. (1999). Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther, 291, 778–784.
   PubMed Web of Science ®Google Scholar
• Paturi DK, Kwatra D, Ananthula HK, Pal D, Mitra AK. (2010). Identification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3). Int J Pharm, 384, 32–38.
   PubMed Web of Science ®Google Scholar
• Reichl S, Kölln C, Hahne M, Verstraelen J. (2011). In vitro cell culture models to study the corneal drug absorption. Expert Opin Drug Metab Toxicol, 7, 559–578.
   PubMed Web of Science ®Google Scholar
• Salomon JJ, Ehrhardt C. (2012). Organic cation transporters in the blood-air barrier: expression and implications for pulmonary drug delivery. Ther Deliv, 3, 735–747.
   PubMedGoogle Scholar
• Salomon JJ, Endter S, Tachon G, Falson F, Buckley ST, Ehrhardt C. (2012). Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells. Eur J Pharm Biopharm, 81, 351–359.
   PubMed Web of Science ®Google Scholar
• Schild L, Roch-Ramel F, Diezi J. (2007). Renal transport of organic ions and uric acid. In: Schrier RW, ed. Diseases of the Kidney and Urinary Tract. Philadelphia: Lippincott Williams and Wilkins (LWW), 218–233.
   Google Scholar
• Sporty JL, Horálková L, Ehrhardt C. (2008). In vitro cell culture models for the assessment of pulmonary drug disposition. Expert Opin Drug Metab Toxicol, 4, 333–345.
   PubMed Web of Science ®Google Scholar
• Steimer A, Haltner E, Lehr CM. (2005). Cell culture models of the respiratory tract relevant to pulmonary drug delivery. J Aerosol Med, 18, 137–182.
   PubMedGoogle Scholar
• Sun D, Yu LX, Hussain MA, Wall DA, Smith RL, Amidon GL. (2004). In vitro testing of drug absorption for drug ‘developability’ assessment: forming an interface between in vitro preclinical data and clinical outcome. Curr Opin Drug Discov Devel, 7, 75–85.
   PubMed Web of Science ®Google Scholar
• Vllasaliu D, Fowler R, Garnett M, Eaton M, Stolnik S. (2011). Barrier characteristics of epithelial cultures modelling the airway and intestinal mucosa: a comparison. Biochem Biophys Res Commun, 415, 579–585.
   PubMed Web of Science ®Google Scholar
• Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, Sai Y, Tsuji A. (1999). Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther, 289, 768–773.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Chidekel A, Shaffer TH. (2010). Cultured human airway epithelial cells (calu-3): a model of human respiratory function, structure, and inflammatory responses. Crit Care Res Pract, 2010.
   PubMedGoogle Scholar